Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Amyloidosis Is Often Underdiagnosed, Undertreated

  |  Issue: July 2017  |  

Nevertheless, amyloidosis “is still a missed diagnosis.” Dr. Libbey encouraged rheumatologists to add it to their list of differential diagnoses.

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

ADVERTISEMENT
SCROLL TO CONTINUE

Causes of AA Amyloid

  • Inflammatory: rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease, juvenile idiopathic arthritis, psoriatic arthritis, colitic arthropathy
  • Infectious: tuberculosis, osteomyelitis, leprosy, substance users/skin poppers, bronchiectasis
  • Autoinflammatory: familial Mediterranean fever, tumor necrosis factor receptor-associated periodic syndrome, cryopyrin-associated periodic syndrome, hyperimmunoglobulinemia D with periodic fever syndrome
  • Tumor: renal cell carcinoma, atrial myxoma, Hodgkins, IgG4 disease

Related Articles

    An Amylodosis Warning & New Drug Hope

    SAN DIEGO—Treatments do exist that can improve the prospects of a patient with the rare disease amyloidosis, but only if clinicians keep the disease in mind and treat the patient before it’s too late, an expert said at the 2017 ACR/ARHP Annual Meeting this past November. He also discussed research that may be close to…

    2015 ACR/ARHP Annual Meeting: Treatments for Transthyretin-Related Amyloidosis Generate Interest from Researchers, Pharmaceuticals

    SAN FRANCISCO—Treatment for transthyretin-related amyloidosis (ATTR) is generating more interest from academic researchers and the pharmaceutical industry, with encouraging early results using a multi-pronged therapeutic approach, a researcher said at a review course held before the 2015 ACR/ARHP Annual Meeting. Amyloidoses are a rare and potentially deadly family of diseases in which misfolded protein builds…